Citation:Bach A,Filipowicz A,S A. Gold,Azeema Latiff,Timothy G. Murray.Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure.Int J Ophthalmol 2017;10(12):1925-1927,doi:10.18240/ijo.2017.12.22
Paracentesis following intravitreal drug injections in maintaining physiologic ocular perfusion pressure
Received:March 02, 2017  Revised:June 14, 2017
Email this Article  Add to Favorites  Print
DOI:10.18240/ijo.2017.12.22
Key Words:anterior chamber paracentesis  intravitreal injection  intraocular pressure  ocular perfusion pressure
Fund Project:
              
AuthorInstitution
Austin Bach Bascom Palmer Eye Institute, University of Miami, Miami, FL 33136, USA
Artur Filipowicz Des Moines University College of Osteopathic Medicine, Des Moines, IA 50312, USA
Aaron S. Gold Murray Ocular Oncology & Retina, Miami, FL 33143, USA
Azeema Latiff Murray Ocular Oncology & Retina, Miami, FL 33143, USA
Timothy G. Murray Murray Ocular Oncology & Retina, Miami, FL 33143, USA
Hits: 378
Download times: 112
Abstract:
      A retrospective analysis was performed of patients who received a paracentesis immediately following an intravitreal injection of bevacizumab or triamcinolone acetonide. These patients were previously diagnosed as having glaucoma, ocular hypertension, or had responded previously with sustained elevated intraocular pressure. Of 1661 procedures were performed. Totally 219 (13%) of the injections were on phakic patients. A median (SD) of 210 μL (40 μL) of aqueous was removed during each paracentesis. There were no reported incidences of any complications. We propose performing a paracentesis immediately following intravitreal injections for patients at risk for ocular hypertension, glaucoma, and retinal vein or artery occlusion.
PMC FullText Html:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733524/
Supplementary Material
PDF Fulltext  Download reader  HTML Fulltext   View/Add Comment